Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 May 24 S-1/A IPO registration (amended)
- 15 Dec 23 S-1/A IPO registration (amended)
- 29 Nov 23 S-1/A IPO registration (amended)
-
19 Oct 23 S-1 IPO registration
NKGN similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 15, 2023, relating to the financial statements of NKGen Biotech, Inc. as of and for the years ended December 31, 2021 and 2022 in the Registration Statement (Form S-1) and related Prospectus of NKGen Biotech, Inc. for the registration of common stock and warrants to purchase common stock.
/s/ Ernst & Young LLP
Irvine, California
October 19, 2023